October 15 2024 - J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity

October 15 2024 - J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity

J&J reports Q3 sales surge of 5.2% despite EPS decline due to M&A activity
AlphaFold’s Nobel Prize is ‘the dawn of a new era’ in mapping drug development potential
Genentech’s Evrysdi helped babies with SMA reach rare milestones in Phase II trial
Walgreens loses another $3 billion and plans to close 1,200 stores
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*
image: